For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription drug costs. The savings it generates allows hospitals to stretch limited resources, sustain vital services and expand access to care where it’s needed most. Currently, 340B is a key priority for the AHA as this program is at risk as potential regulatory, legal and legislative changes in 2026 could diminish these benefits.

In this Leadership Dialogue, I am joined by Aimee Kuhlman, AHA vice president of advocacy grassroots and government relations, and Paulette Davidson, CEO of Monument Health based in Rapid City, S.D. We discuss why the 340B program is important to patients, providers and communities and what’s at stake as changes loom in 2026. Also, we learn how Monument Health uses 340B savings to expand access to care and services in the community, and how we can take action to support participating hospitals by continuing to tell local stakeholders and elected officials the many stories of how the 340B program improves people’s lives.

I hope you find this conversation insightful and strategic. I will be back next month for one last Leadership Dialogue conversation, with incoming AHA Board Chair Marc Boom, M.D.

This conversation was recorded on Nov. 17, 2025. 


Related News Articles

Headline
The Centers for Medicare & Medicaid Services Nov. 14 released preliminary guidance to states on implementing provider tax provisions in the One Big…
Headline
The House is expected to begin a final vote Nov. 12 on the Senate-backed funding package, bringing a potential end to the government shutdown one step closer.…
Headline
The Senate Nov. 10 passed legislation to fund the federal government that will now head to the House for a vote as early as the evening of Nov. 12, as an end…
Headline
The Senate Nov. 9 took a critical first step toward ending the government shutdown as seven Democrats and Sen. Angus King, I-Maine, joined Republicans to…
Chairperson's File
Public
In last month’s Chair File, we talked about some of the key priorities the AHA has for the remainder of 2025, one of which is protecting the 340B Drug Pricing…
Headline
Senate negotiations on a potential funding deal to end the record-long government shutdown are ongoing, and the chamber is likely to continue working through…